SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines
Foreign entity interest: Chiesi Farmaceuticici has an interest in all issues on line 16
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE | 1998-2000 Legislative Assistance to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction |
| AMY JENSEN | 1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Special Affairs |
Health Issues HCR
Preserving US competitiveness and patient access to lifesaving medicines, especially for treatment of rare diseases
Foreign entity interest: Chiesi Farmaceutici is interested in all issues on line 16.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE | 1998-2000 Legislative Assistance to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction |
| AMY JENSEN | 1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Special Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.